News
09-05-2010, 03:07 AM
The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike. While the mortality rates for DCIS remain low, the risk of local recurrence in the breast is high. Standard treatments following surgery include radiation therapy and hormone treatment...
More... (http://mnt.to/f/3Jjf)
More... (http://mnt.to/f/3Jjf)